Endoscopic prognosis in gastric cancer

Joseph Shabot, G. D. Roark, M. Brannan, M. Patterson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sixty-eight patients with gastric adenocarcinoma underwent upper gastrointestinal endoscopy from 1968 to 1975. Tumors were divided into two categories according to their gross characteristics at endoscopy (mass-ulcer or infiltrative), to try to correlate gross morphology and stage at presentation with survival. The median survival in the mass-ulcer group was 31 months, in the infiltrative group, 4.7 months. Mucosal biopsies were positive in 88% of the mass-ulcer group and in 64% of the infiltrative group. Ninety-four percent of patients with infiltrative lesions had stage III or IV disease (regional lymphatic or distant metastasis) at the time of diagnosis, compared to only 55% of the mass-ulcer patients. Endoscopic features consistent with an infiltrating tumor suggest an advanced stage of tumor with a poor prognosis.

Original languageEnglish (US)
Pages (from-to)25-28
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume5
Issue number1
StatePublished - 1983

Fingerprint

Ulcer
Stomach Neoplasms
Neoplasms
Gastrointestinal Endoscopy
Survival
Lymphatic Diseases
Endoscopy
Stomach
Adenocarcinoma
Neoplasm Metastasis
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Shabot, J., Roark, G. D., Brannan, M., & Patterson, M. (1983). Endoscopic prognosis in gastric cancer. Journal of Clinical Gastroenterology, 5(1), 25-28.

Endoscopic prognosis in gastric cancer. / Shabot, Joseph; Roark, G. D.; Brannan, M.; Patterson, M.

In: Journal of Clinical Gastroenterology, Vol. 5, No. 1, 1983, p. 25-28.

Research output: Contribution to journalArticle

Shabot, J, Roark, GD, Brannan, M & Patterson, M 1983, 'Endoscopic prognosis in gastric cancer', Journal of Clinical Gastroenterology, vol. 5, no. 1, pp. 25-28.
Shabot J, Roark GD, Brannan M, Patterson M. Endoscopic prognosis in gastric cancer. Journal of Clinical Gastroenterology. 1983;5(1):25-28.
Shabot, Joseph ; Roark, G. D. ; Brannan, M. ; Patterson, M. / Endoscopic prognosis in gastric cancer. In: Journal of Clinical Gastroenterology. 1983 ; Vol. 5, No. 1. pp. 25-28.
@article{b007135980054b0dbfb31d4388529405,
title = "Endoscopic prognosis in gastric cancer",
abstract = "Sixty-eight patients with gastric adenocarcinoma underwent upper gastrointestinal endoscopy from 1968 to 1975. Tumors were divided into two categories according to their gross characteristics at endoscopy (mass-ulcer or infiltrative), to try to correlate gross morphology and stage at presentation with survival. The median survival in the mass-ulcer group was 31 months, in the infiltrative group, 4.7 months. Mucosal biopsies were positive in 88{\%} of the mass-ulcer group and in 64{\%} of the infiltrative group. Ninety-four percent of patients with infiltrative lesions had stage III or IV disease (regional lymphatic or distant metastasis) at the time of diagnosis, compared to only 55{\%} of the mass-ulcer patients. Endoscopic features consistent with an infiltrating tumor suggest an advanced stage of tumor with a poor prognosis.",
author = "Joseph Shabot and Roark, {G. D.} and M. Brannan and M. Patterson",
year = "1983",
language = "English (US)",
volume = "5",
pages = "25--28",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Endoscopic prognosis in gastric cancer

AU - Shabot, Joseph

AU - Roark, G. D.

AU - Brannan, M.

AU - Patterson, M.

PY - 1983

Y1 - 1983

N2 - Sixty-eight patients with gastric adenocarcinoma underwent upper gastrointestinal endoscopy from 1968 to 1975. Tumors were divided into two categories according to their gross characteristics at endoscopy (mass-ulcer or infiltrative), to try to correlate gross morphology and stage at presentation with survival. The median survival in the mass-ulcer group was 31 months, in the infiltrative group, 4.7 months. Mucosal biopsies were positive in 88% of the mass-ulcer group and in 64% of the infiltrative group. Ninety-four percent of patients with infiltrative lesions had stage III or IV disease (regional lymphatic or distant metastasis) at the time of diagnosis, compared to only 55% of the mass-ulcer patients. Endoscopic features consistent with an infiltrating tumor suggest an advanced stage of tumor with a poor prognosis.

AB - Sixty-eight patients with gastric adenocarcinoma underwent upper gastrointestinal endoscopy from 1968 to 1975. Tumors were divided into two categories according to their gross characteristics at endoscopy (mass-ulcer or infiltrative), to try to correlate gross morphology and stage at presentation with survival. The median survival in the mass-ulcer group was 31 months, in the infiltrative group, 4.7 months. Mucosal biopsies were positive in 88% of the mass-ulcer group and in 64% of the infiltrative group. Ninety-four percent of patients with infiltrative lesions had stage III or IV disease (regional lymphatic or distant metastasis) at the time of diagnosis, compared to only 55% of the mass-ulcer patients. Endoscopic features consistent with an infiltrating tumor suggest an advanced stage of tumor with a poor prognosis.

UR - http://www.scopus.com/inward/record.url?scp=0020665043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020665043&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 25

EP - 28

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 1

ER -